Binnopharm Group Launches New Advertising Campaign for Throat Disease Treatment Drug

Directory of companies

The new campaign is developed in two seasonal versions – summer and winter, united by a single communication concept. After the summer stage is completed, the winter video will be aired.

The drug Lorothricin-Alium shows high sales dynamics, being one of the growth drivers of Binnopharm Group in the retail segment in May 2025 with an increase of +54% in rubles (which significantly outpaces the growth rate of the relevant market: +2%). According to preliminary results of YTD 05'2025, Lorothricin-Alium is one of the top market drivers with a growth of +48% in rubles.

Anton Fedosyuk, Marketing Director of Binnopharm Group: “The summer season is not traditionally associated with sore throats by consumers, however, according to market data, the demand for effective treatment drugs remains significant in the warm season. The release in the low season for the drug is a strategic step based on a deep understanding of consumer behavior and the results of quantitative research. We are confident that consistent work with seasonal demand and an active presence in the media space will allow Lorothricin-Alium to show strong growth.”